1. US Food and Drug Administration. December 13, 2022: Cardiovascular and Renal Drugs Advisory Committee Meeting Announcement. Available from:https://www.fda.gov/advisory-committees/advisory-committee-calendar/december-13-2022-cardiovascular-and-renal-drugs-advisory-committee-meeting-announcement-12132022. Accessed January 4, 2023.
2. Cardiac myosin activation with omecamtiv mecarbil in systolic heart failure;Teerlink;N Engl J Med,2021
3. Identifying treatments for stage C2 heart failure;Yancy;JAMA Cardiol,2022
4. Improving the use of FDA advisory committees;Daval;N Engl J Med,2022